Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;32(7):4829-4837.
doi: 10.1245/s10434-025-17105-2. Epub 2025 May 8.

The Five-Item Modified Frailty Index Predicts Adverse Surgical Outcomes in Patients Undergoing Mastectomy

Laetitia S Chiarella #  1   2 , Lioba Huelsboemer #  1 , Fortunay Diatta #  1 , Felix J Klimitz  1   3 , Alexander J Kammien  1 , Alejandro Kochen  1 , Sam Boroumand  1 , Omar Allam  1 , Martin Kauke-Navarro  1 , Bohdan Pomahac  4
Affiliations

The Five-Item Modified Frailty Index Predicts Adverse Surgical Outcomes in Patients Undergoing Mastectomy

Laetitia S Chiarella et al. Ann Surg Oncol. 2025 Jul.

Abstract

Background: The 5-item modified Frailty Index (mFI-5) is a clinical tool to predict adverse outcomes in surgical patients by assessing five comorbidities: diabetes, hypertension, congestive heart failure, chronic obstructive pulmonary disease, and dependent functional status. It helps to evaluate postoperative complication risks, recovery time, and overall survival, particularly in frail patients undergoing oncological and gynecological surgeries.

Methods: This retrospective cohort study analyzed American College of Surgeons, National Surgical Quality Improvement Program data from adult female patients undergoing mastectomy procedures without reconstruction between 2017 and 2022. Patients were selected based on Current-Procedural-Terminology codes, excluding incomplete or non-breast-related cases. Preoperative, perioperative, and 30-day postoperative data were analyzed using logistic and linear regression models, with the mFI-5 cutoff set at 2.

Results: Between 2017 and 2022, 860 patients underwent mastectomies at Yale Healthcare Network; 19% (n = 163) had mFI score ≥2. High-risk patients (mFI ≥2) were significantly older (66.32 ± 10.83 years) and had a higher body mass index (33.69 ± 7.73, both p < 0.001). Surgical complications occurred in 11.98% of patients, with a higher rate in the high-risk group (22.7% vs. 9.5%, p < 0.001). Adjusted multivariate logistic regression showed an increased risk of complications in frail patients (aOR 2.66; [1.60-4.43], p < 0.001). Although slight reductions in hospital stay and surgery duration were observed for high-risk patients, these differences were not significant. Sensitivity analysis confirmed higher odds of complications, including acute kidney failure (odds ratio [OR] 9.01) and pneumonia (OR 4.10).

Conclusions: The mFI-5 is a robust tool for predicting surgical complications in patients undergoing mastectomy, particularly those with multiple comorbidities.

Keywords: ACS-NSQIP database; Frailty; Modified Frailty Index (mFI-5); Pre-procedural screening; Risk stratification; Surgical outcomes.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors declare no conflicts of interest. Ethical Approval/Informed Consent: IRB Protocol ID: 2000035387, Yale School of Medicine, New Haven, CT.

References

    1. Kim H, Lee SB, Nam S-J, et al. Survival of breast-conserving surgery plus radiotherapy versus total mastectomy in early breast cancer. Ann Surg Oncol. 2021;28:5039–47. - DOI - PubMed
    1. Fu M, Chen Q, Zeng L, Hong T, Zou Q, Yuan Y, et al. Prognosis comparison between nipple-sparing mastectomy and total mastectomy in breast cancer: a case-control study after propensity score matching. Ann Surg Oncol. 2022;29:2221–30. - DOI - PubMed
    1. Guo L, Xie G, Wang R, Yang L, Sun L, Xu M, et al. Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy? BMC Cancer. 2021;21:717. - DOI - PubMed - PMC
    1. Meijers-Heijboer H, van Geel B, van Putten WLJ, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 Mutation. N Engl J Med. 2001;345:159–64. - DOI - PubMed
    1. Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394:1365–75. - DOI - PubMed

LinkOut - more resources